Sheri Dubey

6.3k total citations · 1 hit paper
52 papers, 2.1k citations indexed

About

Sheri Dubey is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Sheri Dubey has authored 52 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 21 papers in Epidemiology and 21 papers in Immunology. Recurrent topics in Sheri Dubey's work include HIV Research and Treatment (18 papers), Viral Infections and Outbreaks Research (16 papers) and Viral Infections and Vectors (13 papers). Sheri Dubey is often cited by papers focused on HIV Research and Treatment (18 papers), Viral Infections and Outbreaks Research (16 papers) and Viral Infections and Vectors (13 papers). Sheri Dubey collaborates with scholars based in United States, Australia and Japan. Sheri Dubey's co-authors include Danilo R. Casimiro, John W. Shiver, Michael Robertson, Lisa Kierstead, Devan V. Mehrotra, Lawrence Corey, Kara S. Cox, M. Juliana McElrath, Steven G. Self and Stephen C. De Rosa and has published in prestigious journals such as The Lancet, Nature Medicine and PLoS ONE.

In The Last Decade

Sheri Dubey

49 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

2008 517 citations M. Juliana McElrath, Sheri Dubey et al. profile →

Peers

Sheri Dubey

VIROL

IMMUN

EPIDE

Zoe Moodie United States

Maria Grazia Pau Netherlands

Charles M. Trubey United States

Sekhar Chakrabarti India

Morgane Rolland United States

Linda S. Klavinskis United Kingdom

Ryan M. Troyer United States

James T. Fuller United States

Daniel C. Freed United States

Peter Abbink United States

Zoe Moodie United States

Sheri Dubey

1.1k ×1.3

VIROL

1.1k ×1.3

IMMUN

837 ×1.1

746 ×1.0

EPIDE

703 ×1.2

Citations per year, relative to Sheri Dubey Sheri Dubey (= 1×) peers Zoe Moodie

Countries citing papers authored by Sheri Dubey

Since Specialization

Citations

This map shows the geographic impact of Sheri Dubey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheri Dubey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheri Dubey more than expected).

Fields of papers citing papers by Sheri Dubey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheri Dubey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheri Dubey. The network helps show where Sheri Dubey may publish in the future.

Co-authorship network of co-authors of Sheri Dubey

This figure shows the co-authorship network connecting the top 25 collaborators of Sheri Dubey. A scholar is included among the top collaborators of Sheri Dubey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheri Dubey. Sheri Dubey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gunn, Bronwyn M., Ryan P. McNamara, Wenyu Guo, et al.. (2023). Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates. Cell Reports. 42(4). 112402–112402. 12 indexed citations

Coller, Beth-Ann, William Lapps, Samantha Bruno, et al.. (2022). Lessons Learned from the Development and Roll-Out of the rVSVΔG-ZEBOV-GP Zaire ebolavirus Vaccine to Inform Marburg Virus and Sudan ebolavirus Vaccines. Vaccines. 10(9). 1446–1446. 6 indexed citations

Plock, Nele, Akshita Chawla, Seth Robey, et al.. (2022). Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach. EBioMedicine. 84. 104264–104264. 9 indexed citations

Simon, Jakub K., Stephen B. Kennedy, Barbara E. Mahon, et al.. (2022). Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials. Vaccine. 40(46). 6599–6606. 11 indexed citations

Giuliano, Anna R., Timothy Wilkin, Oliver Bautista, et al.. (2021). Design of a phase III efficacy, immunogenicity, and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men. Contemporary Clinical Trials. 115. 106592–106592. 23 indexed citations

Antonello, Joseph M., Rebecca J. Grant-Klein, Richard Nichols, et al.. (2020). Serostatus cutoff levels and fold increase to define seroresponse to recombinant vesicular stomatitis virus – Zaire Ebola virus envelope glycoprotein vaccine: An evidence-based analysis. Vaccine. 38(31). 4885–4891. 9 indexed citations

Manoff, Susan B., Sarah L. George, Andrew J. Bett, et al.. (2015). Preclinical and clinical development of a dengue recombinant subunit vaccine. Vaccine. 33(50). 7126–7134. 51 indexed citations

Cox, Kara S., Sheri Dubey, Joseph M. Antonello, et al.. (2015). Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination. Frontiers in Immunology. 6. 553–553. 41 indexed citations

Chiappori, Alberto, Luigi Aurisicchio, Ansuman Bagchi, et al.. (2013). Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors. Journal of Translational Medicine. 11(1). 62–62. 64 indexed citations

10.

Fu, Tong‐Ming, Dai Wang, Daniel C. Freed, et al.. (2012). Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus. Vaccine. 30(52). 7469–7474. 57 indexed citations

11.

Li, Fusheng, Adam C. Finnefrock, Sheri Dubey, et al.. (2011). Mapping HIV-1 Vaccine Induced T-Cell Responses: Bias towards Less-Conserved Regions and Potential Impact on Vaccine Efficacy in the Step Study. PLoS ONE. 6(6). e20479–e20479. 56 indexed citations

12.

Struthers, Mary, Andrew J. Bett, Thomas Wısnıewskı, et al.. (2010). Synthesis and immunological activities of novel agonists of toll-like receptor 9. Cellular Immunology. 263(1). 105–113. 13 indexed citations

13.

Bett, Andrew J., Sheri Dubey, Devan V. Mehrotra, et al.. (2010). Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans. Vaccine. 28(50). 7881–7889. 21 indexed citations

14.

Hutnick, Natalie A., Diane G. Carnathan, Sheri Dubey, et al.. (2010). Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality. PLoS ONE. 5(12). e14385–e14385. 10 indexed citations

15.

Nicholson, Ouzama, James G. Kublin, Xiao Sun, et al.. (2010). Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. AIDS Research and Human Retroviruses. 27(5). 557–567. 16 indexed citations

16.

Cox, Kara S., James H. Clair, Kara J. Sykes, et al.. (2008). DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles. Journal of Virology. 82(16). 8161–8171. 41 indexed citations

17.

Harro, Clayton, Michael Robertson, Michelle Lally, et al.. (2008). Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults. AIDS Research and Human Retroviruses. 25(1). 103–114. 46 indexed citations

18.

Kierstead, Lisa, Sheri Dubey, Timothy W. Tobery, et al.. (2007). Enhanced Rates and Magnitude of Immune Responses Detected against an HIV Vaccine: Effect of Using an Optimized Process for Isolating PBMC. AIDS Research and Human Retroviruses. 23(1). 86–92. 60 indexed citations

19.

Tobery, Timothy W., Sheri Dubey, Daniel C. Freed, et al.. (2006). A Comparison of Standard Immunogenicity Assays for Monitoring HIV Type 1 gag-Specific T Cell Responses in Ad5 HIV Type 1 gag Vaccinated Human Subjects. AIDS Research and Human Retroviruses. 22(11). 1081–1090. 26 indexed citations

20.

Trigona, Wendy L., James H. Clair, Natasha Persaud, et al.. (2003). Intracellular Staining for HIV-Specific IFN-γ Production: Statistical Analyses Establish Reproducibility and Criteria for Distinguishing Positive Responses. Journal of Interferon & Cytokine Research. 23(7). 369–377. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact